Filtros de búsqueda

Lista de obras de

(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients

artículo científico publicado en 2015

5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo

artículo científico publicado en 2013

64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer

artículo científico publicado en 2013

A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines

artículo científico publicado en 2019

A Comprehensive Peptidome Profiling Technology for the Identification of Early Detection Biomarkers for Lung Adenocarcinoma ⬇️

artículo científico publicado el 12 de abril de 2011

A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese Population

scientific article published on 09 October 2019

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

artículo científico publicado en 2017

A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.

artículo científico publicado en 2018

A descriptive analysis of post-chemotherapy development of interstitial lung disease using spontaneous reporting data in Japan

artículo científico publicado en 2014

A double-blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy-induced nausea and vomiting in patients with breast cancer receiving anthracycline and cycloph

artículo científico publicado en 2020

A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer ⬇️

artículo científico publicado el 8 de febrero de 2012

A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma

scientific article published on 02 October 2018

A phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcoma

artículo científico publicado en 2018

A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904).

artículo científico publicado en 2010

A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes

artículo científico publicado en 2019

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer

artículo científico publicado en 2013

A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study

scientific article published on 26 August 2019

A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP

artículo científico publicado en 2018

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

artículo científico publicado en 2010

A tissue microRNA signature that predicts the prognosis of breast cancer in young women

artículo científico publicado en 2017

Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.

artículo científico

Alternative two-step matrix application method for imaging mass spectrometry to avoid tissue shrinkage and improve ionization efficiency

artículo científico publicado en 2013

Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma

artículo científico publicado en 2017

Amrubicin for non-small-cell lung cancer and small-cell lung cancer

artículo científico publicado en 2007

Annual report of the Japanese Breast Cancer Registry for 2017

artículo científico publicado en 2020

Annual report of the Japanese Breast Cancer Society registry for 2016

artículo científico publicado en 2020

Anticancer Agent-Induced Life-Threatening Skin Toxicities: A Database Study of Spontaneous Reporting Data

artículo científico publicado en 2018

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study

artículo científico publicado en 2020

Assessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapy

artículo científico publicado en 2015

BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma

scientific article published on 01 April 2020

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy

artículo científico publicado en 2020

Back with a vengeance: microvascular tumor embolism

artículo científico publicado en 2015

Baseline risk of recurrence in stage I-II endometrial carcinoma.

artículo científico publicado en 2018

Biomarker discordance between primary breast cancer and bone or bone marrow metastases

scientific article published on 01 May 2019

Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography

artículo científico publicado en 2019

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2009

Brain metastasis-related microRNAs in patients with advanced breast cancer

artículo científico publicado en 2019

Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier

artículo científico publicado en 2015

Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer

artículo científico publicado en 2010

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study

artículo científico publicado en 2019

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination With Fulvestrant in Patients With AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer

scientific article published on 20 April 2020

Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy ⬇️

artículo científico publicado el 25 de junio de 2012

Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma ⬇️

artículo científico publicado el 5 de enero de 2012

Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy

artículo científico publicado en 2012

Clinical status of Von Hippel-Lindau disease associated pheochromocytoma in Japan: a national epidemiologic survey ⬇️

artículo científico publicado el 1 de mayo de 2012

Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.

artículo científico publicado en 2012

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanes

artículo científico publicado en 2019

Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials

artículo científico publicado en 2016

Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal

artículo científico publicado en 2012

Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)

scientific article published on 01 February 2020

Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals

artículo científico publicado en 2014

Desmoplastic small round cell tumor with sphere-like clusters mimicking adenocarcinoma

artículo científico publicado en 2014

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer

artículo científico publicado en 2008

Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease ⬇️

artículo científico publicado el 28 de septiembre de 2010

Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification

artículo científico publicado en 2007

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan

artículo científico publicado en 2017

Dose-finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors

artículo científico publicado en 2018

Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-M arrest in A549 cells

artículo científico publicado en 2006

Drug induced interstitial lung disease in oncology phase I trials.

scientific article published on 29 September 2016

Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.

artículo científico publicado en 2017

EXTH-50. DEVELOPMENT OF INVESTIGATOR INITIATED CLINICAL TRIAL OF TERT-TARGETING THERAPY USING ERIBULIN MESYLATE IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Efficacy and Safety of Pazopanib for Recurrent or Metastatic Solitary Fibrous Tumor.

artículo científico publicado en 2018

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

artículo científico publicado en 2017

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial

scientific article published on 03 September 2019

Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites

artículo científico publicado en 2020

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

artículo científico publicado en 2018

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells

artículo científico publicado en 2012

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts

artículo científico publicado en 2019

Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging.

artículo científico publicado en 2017

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.

artículo científico publicado en 2014

Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults

scientific article published on 21 February 2020

Expression of angiogenesis‐related gene profiles and development of resistance to tyrosine‐kinase inhibitor in advanced renal cell carcinoma: Characterization of sorafenib‐resistant cells derived from a cutaneous metastasis ⬇️

artículo científico publicado el 4 de febrero de 2013

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death

artículo científico publicado en 2009

Fc-Gamma receptor polymorphism and gene expression of peripheral blood mononuclear cells in patients with HER2-positive metastatic breast cancer receiving single-agent trastuzumab.

artículo científico publicado en 2015

Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice

artículo científico publicado en 2010

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study

article

Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study

scientific article published on 15 April 2019

Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy

artículo científico publicado en 2017

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy

scientific article published on 02 August 2019

Gene aberration profile of tumors of adolescent and young adult females.

artículo científico publicado en 2017

Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population

artículo científico publicado en 2014

Granulocyte-colony stimulating factor producing squamous cell carcinoma of the renal pelvis: a case report

artículo científico publicado en 2010

HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix

scientific article published on 23 July 2020

Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection

artículo científico publicado en 2012

High-throughput functional evaluation of BRCA2 variants of unknown significance

scientific article published on 22 May 2020

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

artículo científico publicado en 2009

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

artículo científico publicado en 2010

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

artículo científico publicado en 2008

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors

artículo científico publicado en 2010

Insights Into Breast Cancer in the East vs the West: A Review

scientific article published on 16 May 2019

Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40-44 years

artículo científico publicado en 2018

LC-MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid-liquid partition in plasma of Trastuzumab emtansine-treated breast cancer patients.

artículo científico publicado en 2017

Localized Fournier's gangrene of the penis: a case report

artículo científico publicado en 2009

Long Non-coding NR2F1-AS1 is Associated with Tumor Recurrence in Estrogen Receptor-positive breast cancers

scientific article published on 11 May 2020

Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.

artículo científico publicado en 2018

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

artículo científico publicado en 2009

Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.

artículo científico publicado en 2015

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles

artículo científico publicado en 2007

Molecular imaging using PET for breast cancer

artículo científico

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer

artículo científico publicado en 2020

Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer

artículo científico publicado en 2008

Nucleostemin expression in invasive breast cancer

artículo científico publicado en 2014

Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer

artículo científico publicado en 2009

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience

artículo científico publicado en 2007

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system

scientific article published on 28 July 2018

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

artículo científico publicado en 2011

Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.

artículo científico publicado en 2017

Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey ⬇️

artículo científico publicado el 31 de marzo de 2013

Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

artículo científico publicado en 2017

Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study

artículo científico publicado en 2020

Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs

artículo científico publicado en 2020

Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function.

artículo científico publicado en 2019

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors

artículo científico publicado en 2017

Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B

Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate Cancer

artículo científico publicado en 2020

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

artículo científico publicado en 2011

Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer

artículo científico publicado en 2014

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumors.

artículo científico publicado en 2010

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses

artículo científico publicado en 2006

Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer

artículo científico publicado en 2007

Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer.

artículo científico publicado en 2018

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours

artículo científico publicado en 2019

Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer

artículo científico publicado en 2009

Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study

artículo científico publicado en 2010

Photodynamic diagnosis of positive margin during radical prostatectomy: Preliminary experience with 5‐aminolevulinic acid ⬇️

artículo científico publicado el 9 de junio de 2011

Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide

artículo científico publicado en 2013

Plasma protoporphyrin IX following administration of 5-aminolevulinic acid as a potential tumor marker

artículo científico publicado en 2015

Platinum-free interval affects efficacy of following treatment for platinum-refractory or -resistant ovarian cancer

artículo científico publicado en 2019

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials.

artículo científico publicado en 2017

Primary yolk sac tumor of the omentum: a case report and literature review

artículo científico publicado en 2012

Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma

scientific article published on 08 April 2020

Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers

artículo científico publicado en 2013

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site

artículo científico publicado en 2018

Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy

artículo científico publicado en 2017

Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

artículo científico publicado en 2017

Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor ⬇️

artículo científico publicado el 23 de marzo de 2011

Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan

artículo científico publicado en 2019

Regulatory and Operational Challenges in Conducting Asian International Academic Trial for Expanding the Indications of Cancer Drugs

scientific article published on 31 December 2020

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

artículo científico publicado en 2009

Reply to T.J.A. Dekker

artículo científico publicado en 2020

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation

scientific article published on 06 March 2020

SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression

artículo científico publicado en 2017

SMARCB-1 deficient squamous cell carcinoma of a mediastinal cyst

scientific article published on 14 September 2018

SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression ⬇️

artículo científico publicado el 1 de diciembre de 2011

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer

article published in 2019

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

artículo científico publicado en 2017

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

artículo científico publicado en 2010

Second-line chemotherapy in patients with primary unknown cancer

artículo científico publicado en 2011

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

scientific article published on 27 November 2018

Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer

artículo científico publicado en 2019

Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults

scientific article published on 03 June 2020

Skeletal metastases in non-small cell lung cancer: a retrospective study

scientific article published on 23 April 2007

Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer

artículo científico publicado en 2009

Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)

scientific article published on 01 December 2019

Successful response of reccurent adult wilms' tumor to multiagent chemotherapy

artículo científico publicado en 2009

Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience

artículo científico publicado en 2017

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment

artículo científico publicado en 2020

Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.

artículo científico publicado en 2018

Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase

artículo científico publicado en 2008

TERT promoter hotspot mutations in breast cancer.

artículo científico publicado en 2017

Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

scientific article published on 25 March 2020

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients

scientific article published on 16 April 2020

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site

scientific article published on 01 February 2019

The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma

artículo científico publicado en 2017

The Use of PET/CT and Bone Marrow Aspiration/Biopsy in Initial Staging Evaluation of Adolescent and Adult Ewing Sarcomas

artículo científico publicado en 2017

The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer

artículo científico publicado el 1 de marzo de 2012

The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.

artículo científico publicado en 2012

The expression and clinical significance of ribophorin II (RPN2) in human breast cancer

artículo científico publicado en 2015

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

artículo científico publicado en 2010

The notorious "drug lag" for oncology drugs in Japan

scientific article published on February 2011

The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer.

artículo científico publicado en 2010

Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma

artículo científico publicado en 2019

Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer

artículo científico publicado en 2008

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

scientific article published on 11 December 2019

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study

article published in 2019

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study

artículo científico publicado en 2019

Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts

Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study

artículo científico publicado en 2018

Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma

artículo científico publicado en 2020

Treatment strategies for recurrent ovarian cancer in older adult patients in Japan: a study based on real-world data

artículo científico publicado en 2020

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

artículo científico publicado en 2011

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.

artículo científico publicado en 2017

Undifferentiated Prostate Cancer Treated with Radiation Therapy

artículo científico publicado en 2016

Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response.

artículo científico publicado en 2013

Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma

artículo científico publicado en 2011

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma

artículo científico publicado en 2017

Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET.

artículo científico publicado en 2017

Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging

scientific article published on 23 September 2020

Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity.

artículo científico publicado en 2017

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease

artículo científico publicado en 2019

Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival ⬇️

artículo científico publicado en 2014

[A case of carcinoid tumor arising from a horseshoe kidney]

artículo científico publicado en 2009

[A case of retroperitoneal solitary fibrous tumor]

artículo científico publicado en 2009

[Anti-angiogenic therapy in breast cancer]

[Experience in the treatment of eight cases of Fournier's gangrene]

artículo científico publicado en 2009

[First experiences of laparoscopic radical cystectomy]

artículo científico publicado en 2013

[Ifosfamide and Paclitaxel for Recurrent or Metastatic Uterine Carcinosarcoma]

scientific article published on 01 October 2019

[LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION]

scientific article published on 01 January 2019

[The role to be played by the specialty of tumor chemotherapy: a discussion]

artículo científico publicado en 2009

＜Editors' Choice＞ Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group.

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda